BioAstin Supreme 6 mg

BioAstin Supreme 6 mg

BioAstin4.5 (1,578 ratings)
Format:Softgel Quantity: 60 Vegan Soft Gel(s) · 30 servings
Goals

Product analysis

68 out of 100

BioAstin Supreme 6 mg offers astaxanthin that may help maintain skin condition, although the human evidence is limited. The cost is favorable for the astaxanthin provided.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality41

Vitamin E uses a favorable natural form, and the algal astaxanthin source is identified. The olive-oil and fat details are less specific, leaving the complete formula quality uncertain.

Ingredient Transparency78

The listed amounts and forms of vitamin E and astaxanthin are disclosed. The olive-oil and fat types lack details, limiting a fuller comparison.

Value For Money88

The cost is favorable for the astaxanthin supplied. Vitamin E offers less convincing ingredient value, while olive-oil value remains uncertain.

Customer Satisfaction79

Customer ratings are positive across more than a thousand reviews. The substantial feedback gives a broad view of satisfaction, without proving the range of health claims.

Product Focus68

Astaxanthin has limited support for selected skin measures and blood-fat markers. The broader range of memory, eye and joint aims does not establish equally broad results.

Format
Softgel
Container
60 Vegan Soft Gel(s)
Per serving
$0.81
Customer rating
4.5 · 1,578 ratings
Report analysis

Goals

Eye Health
Impact
High effect
C Ingredient FitD+ PathwaysB- EvidenceA- Formulation Logic
Vitamin E · 30 IUAstaxanthin · 12 mg

Astaxanthin has limited findings for visual performance during screen use, with favorable acuity results restricted to adults aged at least 40 in a small sponsored trial. Several other visual outcomes were unchanged, so the findings do not establish broad improvements in sight. The declared active amount meets the saved comparison, without proving added benefit above the trial exposure. Vitamin E has no resolved individual amount.

How this product is rated for Eye Health

Ingredient fit63

Relevant nutrients appear within a broader formula, limiting the specific focus on vision. The amount match is limited, including unresolved or smaller ingredient contributions.
Goal fit
Relevant nutrients appear within a broader formula, limiting the specific focus on vision.
Dose adequacy
The amount match is limited, including unresolved or smaller ingredient contributions.

Pathways53

The strongest represented aspect is focusing-muscle function; this does not establish measured visual improvement. The findings concentrate on one vision-related aspect, with limited breadth.
Depth
The strongest represented aspect is focusing-muscle function; this does not establish measured visual improvement.
Breadth
The findings concentrate on one vision-related aspect, with limited breadth.

Evidence70

Astaxanthin provides the strongest recognized evidence here, subject to its population and preparation limitations. The qualifying preparations are recognized in the saved comparison, without establishing benefit outside the reviewed research context.
Evidence strength
Astaxanthin provides the strongest recognized evidence here, subject to its population and preparation limitations.
Studied preparation
The qualifying preparations are recognized in the saved comparison, without establishing benefit outside the reviewed research context.

Formulation logic88

No listed ingredient conflict was matched; this does not establish individual suitability. Vitamin E lacks a qualifying individual amount, limiting its contribution.
Partner coverage
No required partner is missing for the recognized ingredients; this does not establish synergy or a complete AREDS regimen.
Conflicts
No listed ingredient conflict was matched; this does not establish individual suitability.
Effective doses
Vitamin E lacks a qualifying individual amount, limiting its contribution.
Study evidence
Vitamin E Disputed 35 studies
Inflammation
Impact
High effect
C Ingredient FitD+ PathwaysB+ EvidenceA- Formulation Logic
Vitamin E · 30 IUAstaxanthin · 12 mg

Astaxanthin has a limited inflammatory-marker signal from a small trial in healthy young women. A lower exposure reduced CRP, while a higher exposure increased some cytokines and did not support a steadily increasing benefit. The 12 mg per serving receives full amount consideration in the saved result, but does not establish stronger anti-inflammatory effects or clinical benefit. Vitamin E’s amount remains unresolved.

How this product is rated for Inflammation

Ingredient fit61

Relevant ingredients sit within a broader formula, limiting its focus on this particular goal. Smaller or unresolved amounts limit the comparison with the referenced exposures.
Goal fit
Relevant ingredients sit within a broader formula, limiting its focus on this particular goal.
Dose adequacy
Smaller or unresolved amounts limit the comparison with the referenced exposures.

Pathways52

Oxidative and mitochondrial stress is the strongest recorded mechanism; this does not establish broad clinical benefit.
Depth
Oxidative and mitochondrial stress is the strongest recorded mechanism; this does not establish broad clinical benefit.
Breadth
Only one inflammatory mechanism reached the required coverage level.

Evidence82

Astaxanthin leads the saved evidence finding, with its specific population and outcome limitations still applying.
Evidence strength
Astaxanthin leads the saved evidence finding, with its specific population and outcome limitations still applying.
Studied preparation
Contributing preparations matched those recognized in the saved result; this does not establish a trial of the complete product.

Formulation logic88

No missing required partner or configured conflict reduced recognized contributions. An unresolved amount limits coverage of the comparison threshold.
Partner coverage
No missing required partner reduced recognized contributions; this does not demonstrate extra benefit from combining ingredients.
Conflicts
No configured ingredient conflict was identified in the supplied calculation.
Effective doses
Vitamin E’s unresolved amount did not reach the minimum comparison threshold.
Study evidence
Vitamin E Supportive 20 studies
Skin Health
Impact
High effect
C+ Ingredient FitC- PathwaysA- EvidenceA- Formulation Logic
Astaxanthin · 12 mgVitamin E · 30 IU

Astaxanthin has limited human evidence for maintaining skin condition and changing UV-response measures. Small studies do not establish general reversal of ageing or sunscreen-equivalent protection.

How this product is rated for Skin Health

Ingredient fit67

The relevant ingredients primarily provide nutritional support within a broader formula. Their saved amount findings do not establish extra cosmetic benefit.
Goal fit
Relevant skin ingredients share the formula with ingredients aimed at other needs.
Dose adequacy
The credited amounts only partly meet the saved references; lower or undisclosed amounts limit their contribution.

Pathways59

The strongest saved connection is to uv antioxidant defence. Ingredient roles and limited outcome evidence should not be read as proven cosmetic improvements.
Depth
The main connection is to uv antioxidant defence, with the amount and ingredient limitations carried into the finding.
Breadth
Only one targeted pathway reaches the saved coverage threshold, so the connection is narrow.

Evidence87

Astaxanthin leads the saved evidence finding. The supplied scientific context limits claims to the relevant nutritional role or preparation-specific outcomes.
Evidence strength
Astaxanthin provides the strongest saved evidence contribution; this does not establish broad cosmetic improvement.
Studied preparation
The credited preparations meet the saved preparation checks, while the supplied evidence still limits transfer to routine skin outcomes.

Formulation logic88

The credited ingredients need no missing partner, and no configured conflicts were identified. Those findings do not establish added benefit from combining ingredients.
Partner coverage
The credited ingredients can contribute without an additional required partner.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
Some credited ingredients fall below the saved amount threshold: Vitamin E.
Study evidence
Vitamin E Supportive 38 studies
Cardiovascular Support
Impact
High effect
C+ Ingredient FitC- PathwaysB EvidenceA- Formulation Logic
Astaxanthin · 12 mgVitamin E · 30 IU

Astaxanthin may affect triglyceride and HDL markers, based on a small trial in adults with mildly elevated lipids. Those findings did not show improved LDL or establish fewer cardiovascular events. The serving supplies 12 mg of declared astaxanthin from Haematococcus pluvialis. Vitamin E has no confirmed amount and adds no amount-based contribution.

How this product is rated for Cardiovascular Support

Ingredient fit67

Astaxanthin provides the meaningful contribution; vitamin E has no confirmed amount.
Goal fit
Astaxanthin supplies the clear goal connection, alongside an unquantified vitamin E declaration.
Dose adequacy
Astaxanthin reaches the saved amount plateau; vitamin E's unknown amount prevents an additional amount-based contribution.

Pathways57

The saved findings concentrate on triglyceride metabolism, without meaningful coverage of the other cardiovascular areas.
Depth
Triglyceride metabolism is the strongest represented area.
Breadth
Only triglyceride metabolism reaches the saved coverage threshold.

Evidence79

Astaxanthin has limited lipid-marker findings from a small trial, with its declared preparation recognized.
Evidence strength
Astaxanthin provides the strongest saved support, limited by a small lipid-marker evidence base.
Studied preparation
The declared astaxanthin preparation is recognized in the supplied findings.

Formulation logic88

Astaxanthin meets the saved amount threshold, while vitamin E cannot be confirmed against it. No evaluated partner gap or ingredient conflict was identified.
Partner coverage
The counted ingredients work alone or have their listed partners; this does not establish additional benefit from combining them.
Conflicts
No evaluated ingredient conflict was identified in the supplied facts.
Effective doses
Astaxanthin meets the saved amount threshold; vitamin E has no confirmed amount.
Study evidence
Vitamin E Mixed 79 studies
Longevity
Impact
High effect
C+ Ingredient FitC PathwaysB+ EvidenceA- Formulation Logic
Astaxanthin · 12 mg

Astaxanthin has limited support for maintaining selected skin measures in women, without evidence of whole-body aging or lifespan effects.

How this product is rated for Longevity

Ingredient fit66

The formula covers broader nutritional or product purposes, so only part of its ingredient mix relates to the assessed aging roles. Amount support is partial.
Goal fit
The formula covers broader nutritional or product purposes, so only part of its ingredient mix relates to the assessed aging roles.
Dose adequacy
Included amounts only partly meet the saved amount criteria; small or unknown quantities limit the findings without establishing ineffectiveness.

Pathways60

The main saved connection is antioxidant defence. Coverage is concentrated in one pathway rather than spread broadly.
Depth
The strongest saved connection is antioxidant defence; this describes an ingredient role rather than a demonstrated slowing of aging.
Breadth
Only one assessed pathway met the saved coverage requirement, so the findings do not indicate broad coverage of aging-related functions.

Evidence82

Astaxanthin supplies the strongest included evidence in the saved findings; the supplied scientific context limits transfer to routine anti-aging use.
Evidence strength
Astaxanthin supplies the strongest included evidence in the saved findings; the supplied scientific context limits transfer to routine anti-aging use.
Studied preparation
The saved findings recognize the included preparations as studied; this does not establish benefit for the finished product.

Formulation logic88

No required ingredient partner was missing in the saved findings; this does not establish a combined anti-aging benefit. No configured ingredient conflict was identified in the supplied findings.
Partner coverage
No required ingredient partner was missing in the saved findings; this does not establish a combined anti-aging benefit.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
Some counted ingredients fall below the saved minimum amount criterion: Vitamin E.
Study evidence
Vitamin E Supportive 19 studies
Cognitive Support
Impact
High effect
B- Ingredient FitC- PathwaysB EvidenceA+ Formulation Logic
Astaxanthin · 12 mg

Astaxanthin has antioxidant relevance, but that mechanism does not establish improved memory or attention. In the supplied trial in older adults reporting forgetfulness, changes within treatment groups did not clearly separate from placebo. The serving amount therefore does not establish routine cognitive improvement or a benefit from taking more.

How this product is rated for Cognitive Support

Ingredient fit71

Astaxanthin contributes to the saved ingredient-fit finding. The retained amounts reach their reference comparisons.
Goal fit
The retained ingredients and the product’s other active ingredients and linked uses determine how specifically the formula addresses cognition.
Dose adequacy
The retained amounts reach the saved reference comparisons; those comparisons do not establish effective doses for broad cognitive enhancement.

Pathways57

The strongest recorded connection is oxidative and inflammatory protection. Coverage is concentrated in one tracked pathway.
Depth
The strongest recorded connection is oxidative and inflammatory protection; this mapping does not establish an improvement in cognitive performance.
Breadth
Only one tracked pathway reaches the coverage threshold, leaving the recorded coverage narrow.

Evidence79

Astaxanthin leads the saved evidence finding. The supplied limitations determine whether this concerns narrow tasks, selected populations or normal nutritional roles.
Evidence strength
Astaxanthin leads the saved evidence finding; the supplied task, population and preparation limitations still restrict the cognitive benefits that can be described.
Studied preparation
The saved preparation comparison recognizes the retained forms; it does not establish a clinical trial of this complete product.

Formulation logic100

No required partner was missing and no configured conflict was found. The retained ingredients meet the minimum amount criterion.
Partner coverage
No missing required partner was identified for the retained ingredients. This does not establish extra benefit from combining them.
Conflicts
No configured ingredient conflict was identified; this does not establish overall safety or individual suitability.
Effective doses
All retained ingredients meet the minimum amount criterion; this is not a proven effective cognitive dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Calories
10 Calorie(s)
Total Fat
1 Gram(s)
Vitamin E (D-Alpha-Tocopherol)
30 IU 53
Olive Oil
800 mg
Astaxanthin, Natural (Haematococcus pluvialis)
12 mg 81
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
C+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value
A serving provides 12 mg of astaxanthin from Haematococcus pluvialis algae. Based on the whole-product serving price, it costs about $0.07 per mg of astaxanthin.
How this ingredient is rated

Active Ingredient Quality & Bioavailability68

The saved facts identify Haematococcus pluvialis algae as the astaxanthin source. A trademarked ingredient claim is also recorded. The saved facts do not record a liposomal or water-dispersible formulation claim.
Biological Source Quality
The saved facts identify Haematococcus pluvialis algae as the astaxanthin source.
Formulation Technology
The saved facts do not record a liposomal or water-dispersible formulation claim.
Branded Ingredient Standard
A trademarked astaxanthin ingredient is recorded; that claim alone does not independently verify its manufacturing.

Dose, Safety & Label Transparency84

The serving provides 12 mg of astaxanthin. The saved facts do not establish whether the packaging protects the astaxanthin from light.
Clinical Potency per Serving
The serving provides 12 mg of astaxanthin.
Active Astaxanthin Yield Transparency
The active astaxanthin amount is listed separately as 12 mg per serving.
Ingredient Stability & Packaging
The saved facts do not establish whether the packaging protects the astaxanthin from light.

Value100

Based on the whole-product serving price, astaxanthin costs about $0.07 per mg, low in this comparison.
Price per Milligram of Active Astaxanthin
Based on the whole-product serving price, astaxanthin costs about $0.07 per mg, low in this comparison.
D Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyD- Value
The serving provides 30 IU of vitamin E as d-alpha-tocopherol, a natural d-alpha form. A whole-product serving costs about $0.82.
How this ingredient is rated

Active Ingredient Quality & Bioavailability46

D-alpha-tocopherol is a natural d-alpha form of vitamin E. The saved facts do not establish a mixed-tocopherol complex or tocotrienols.
Natural (d-alpha) vs. Synthetic (dl-alpha)
D-alpha-tocopherol is a natural d-alpha form of vitamin E.
Mixed Tocopherol Isomer Diversity
The saved facts do not establish a mixed-tocopherol complex or amounts of gamma and delta tocopherols.
Tocotrienol Complex Inclusion
The saved facts do not establish the presence of tocotrienols.

Dose, Safety & Label Transparency66

The serving provides 30 IU of vitamin E. The recorded form is d-alpha-tocopherol.
Therapeutic Dosage Range
The saved vitamin E amount is 30 IU per serving.
Label Transparency and Isomer Specificity
The saved facts identify d-alpha-tocopherol and a total vitamin E amount; individual isomer weights are not recorded.

Value40

A whole-product serving costs about $0.82 and includes natural d-form vitamin E.
Cost per Natural-Form Therapeutic Serving
A whole-product serving costs about $0.82 and includes natural d-form vitamin E.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia.
    Ciaraldi TP; Boeder SC; Mudaliar SR; Giovannetti ER; Henry RR; Pettus JH · Diabetes, obesity & metabolism · 2023
    Randomized trial34 participantsCardiovascular Support forAstaxanthin
  2. Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis.
    Wan S; Wu W; Zhang Y; He J; Wang X; An P; Luo J; Zhu Y; Luo Y · Nutrients · 2024
    Meta-analysisCardiovascular Support Heart Health forAstaxanthin
  3. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia.
    Yoshida H; Yanai H; Ito K; Tomono Y; Koikeda T; Tsukahara H; Tada N · Atherosclerosis · 2010
    Randomized trial61 participantsCardiovascular Support Heart Health forAstaxanthin
  4. Effects of Astaxanthin Supplementation on Glycemic Control and Lipid Profile in Patients With Prediabetes and Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
    Molani-Gol R; Bohlouli Sardroudi S; Rafraf M · Nutrition and metabolic insights · 2026
    Meta-analysis403 participants9 studies pooledCardiovascular Support Heart Health forAstaxanthin
  5. Astaxanthin Supplemented with High-Intensity Functional Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity.
    Saeidi A; Nouri-Habashi A; Razi O; Ataeinosrat A; Rahmani H; Mollabashi SS; Bagherzadeh-Rahmani B; Aghdam SM; Khalajzadeh L; Al Kiyumi MH; Hackney AC; Laher I; Heinrich KM; Zouhal H · Nutrients · 2023
    Randomized trial68 participantsCardiovascular Support forAstaxanthin
  6. Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
    Loffredo L; Perri L; Di Castelnuovo A; Iacoviello L; De Gaetano G; Violi F · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2016
    Meta-analysis16 studies pooledCardiovascular Support forVitamin E
  7. Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
    Chen B; Li Y; Li Z; Hu X; Zhen H; Chen H; Nie C; Hou Y; Zhu S; Xiao L; Li T · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2025
    Randomized trial90 participantsCardiovascular Support forVitamin E
  8. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
    Lonn E; Bosch J; Yusuf S; Sheridan P; Pogue J; Arnold JM; Ross C; Arnold A; Sleight P; Probstfield J; Dagenais GR; HOPE and HOPE-TOO Trial Investigators · JAMA · 2005
    Randomized trial9,541 participantsCardiovascular Support forVitamin E
  9. Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
    Liu Z; He Z; Xing Y · Journal of nutritional science · 2026
    Cohort study34,955 participantsCardiovascular Support forVitamin E
  10. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
    Chin SF; Ibahim J; Makpol S; Abdul Hamid NA; Abdul Latiff A; Zakaria Z; Mazlan M; Mohd Yusof YA; Abdul Karim A; Wan Ngah WZ · Nutrition & metabolism · 2011
    Randomized trial62 participantsCardiovascular Support forVitamin E
  11. Effects of astaxanthin-rich Haematococcus pluvialis extract on cognitive function: a randomised, double-blind, placebo-controlled study.
    Katagiri M; Satoh A; Tsuji S; Shirasawa T · Journal of clinical biochemistry and nutrition · 2012
    Randomized trial96 participantsCognitive Support forAstaxanthin
  12. Effect of astaxanthin-rich extract derived from Paracoccus carotinifaciens on cognitive function in middle-aged and older individuals.
    Hayashi M; Ishibashi T; Maoka T · Journal of clinical biochemistry and nutrition · 2020
    Clinical trial54 participantsCognitive Support forAstaxanthin
  13. The Effects of Astaxanthin on Cognitive Function and Neurodegeneration in Humans: A Critical Review.
    Queen CJJ; Sparks SA; Marchant DC; McNaughton LR · Nutrients · 2024
    Narrative reviewCognitive Support forAstaxanthin
  14. Effects of Astaxanthin Supplementation on Fatigue, Motor Function and Cognition: A Meta-Analysis of Randomized Controlled Trials.
    Liu C; Dong X; Jia J; Ha M · Biological research for nursing · 2024
    Meta-analysis346 participants11 studies pooledCognitive Support forAstaxanthin
  15. Astaxanthin and improvement of dementia: A systematic review of current clinical trials.
    Utomo NP; Pinzon RT; Latumahina PK; Damayanti KRS · Cerebral circulation - cognition and behavior · 2024
    Systematic reviewCognitive Support forAstaxanthin
  16. Benefits and Safety of Astaxanthin in the Treatment of Mild-To-Moderate Dry Eye Disease.
    Tian L; Wen Y; Li S; Zhang P; Wang Y; Wang J; Cao K; Du L; Wang N; Jie Y · Frontiers in nutrition · 2022
    Single-arm trial60 participantsEye Health forAstaxanthin
  17. Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial.
    Hecht KA; Marwah M; Wood V; Nishida Y; Bach AE; Gerson J; Hom MM; Schnackenberg J; Raote S; Srivastava S; Negi P; Caston E · Advances in therapy · 2025
    Randomized trial64 participantsEye Health forAstaxanthin
  18. Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study.
    Sekikawa T; Kizawa Y; Li Y; Miura N · Journal of clinical biochemistry and nutrition · 2023
    Randomized trial60 participantsEye Health forAstaxanthin
  19. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential.
    Kidd P · Alternative medicine review : a journal of clinical therapeutic · 2012
    Narrative reviewEye Health Longevity forAstaxanthin
  20. Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials.
    Martinez-Perez C; Oliveira AP · Nutrients · 2026
    Systematic review9 studies pooledEye Health forAstaxanthin